BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Minority Interest (2018 - 2026)

BiomX's (PHGE) quarterly Minority Interest came in at $6.8 million in Q2 2026, down 89.68% quarter-over-quarter from $65.5 million in Q3 2019.

Analysis

BiomX (PHGE) Minority Interest (2018 - 2026) Analysis & Trends

BiomX has disclosed Minority Interest across 3 years of filings, most recently posting $6.8 million for Q2 2026.

  • In Q2 2026, Minority Interest changed N/A year-over-year to $6.8 million; the TTM figure through Jun 2026 stood at $6.8 million (changed N/A YoY), while the FY2019 annual figure was $65.7 million, changed N/A from the prior year.
  • Minority Interest came in at $6.8 million for Q2 2026 at BiomX, down from $65.5 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $6.8 million in Q2 2026 to a low of $6.8 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 BiomX 17.33 Mn 16.75 Mn 97,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.76 Mn
Sep 30, 2019 65.46 Mn
Jun 30, 2019 65.75 Mn
Mar 31, 2019 65.69 Mn
Dec 31, 2018 65.41 Mn